Anti-E2F5 monoclonal antibody
Pre-made anti-E2F5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to E2F5/E2F5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0734-Ab-1/ GM-Tg-hg-IP0734-Ab-2 | Anti-Human E2F5 monoclonal antibody | Human |
GM-Tg-rg-IP0734-Ab-1/ GM-Tg-rg-IP0734-Ab-2 | Anti-Rat E2F5 monoclonal antibody | Rat |
GM-Tg-mg-IP0734-Ab-1/ GM-Tg-mg-IP0734-Ab-2 | Anti-Mouse E2F5 monoclonal antibody | Mouse |
GM-Tg-cynog-IP0734-Ab-1/ GM-Tg-cynog-IP0734-Ab-2 | Anti-Cynomolgus/ Rhesus macaque E2F5 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0734-Ab-1/ GM-Tg-felg-IP0734-Ab-2 | Anti-Feline E2F5 monoclonal antibody | Feline |
GM-Tg-cang-IP0734-Ab-1/ GM-Tg-cang-IP0734-Ab-2 | Anti-Canine E2F5 monoclonal antibody | Canine |
GM-Tg-bovg-IP0734-Ab-1/ GM-Tg-bovg-IP0734-Ab-2 | Anti-Bovine E2F5 monoclonal antibody | Bovine |
GM-Tg-equg-IP0734-Ab-1/ GM-Tg-equg-IP0734-Ab-2 | Anti-Equine E2F5 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP0734-Ab-1/ GM-Tg-hg-IP0734-Ab-2; GM-Tg-rg-IP0734-Ab-1/ GM-Tg-rg-IP0734-Ab-2; GM-Tg-mg-IP0734-Ab-1/ GM-Tg-mg-IP0734-Ab-2; GM-Tg-cynog-IP0734-Ab-1/ GM-Tg-cynog-IP0734-Ab-2; GM-Tg-felg-IP0734-Ab-1/ GM-Tg-felg-IP0734-Ab-2; GM-Tg-cang-IP0734-Ab-1/ GM-Tg-cang-IP0734-Ab-2; GM-Tg-bovg-IP0734-Ab-1/ GM-Tg-bovg-IP0734-Ab-2; GM-Tg-equg-IP0734-Ab-1/ GM-Tg-equg-IP0734-Ab-2 |
Products Name | Anti-E2F5 monoclonal antibody |
Format | mab |
Target Name | E2F5 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-E2F5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP0734-Ag-1 | Recombinant multi-species E2F5/ E2F-5 protein |
ORF Viral Vector | vGMLP001233 | human E2F5 Lentivirus particle |
ORF Viral Vector | pGMLP001233 | human E2F5 Lentivirus plasmid |
ORF Viral Vector | pGMLPm005286 | mouse E2f5 Lentivirus plasmid |
ORF Viral Vector | vGMLPm005286 | mouse E2f5 Lentivirus particle |
Target information
Target ID | GM-IP0734 |
Target Name | E2F5 |
Gene ID | 1875,13559,116651,703352,611103,101096875,539427,100056139 |
Gene Symbol and Synonyms | E2F-5,E2F5 |
Uniprot Accession | Q15329,Q62814 |
Uniprot Entry Name | E2F5_HUMAN,E2F5_RAT |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000133740 |
Target Classification | N/A |
The target: E2F5, gene name: E2F5, also named as E2F-5. The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionarily conserved domains that are present in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein is differentially phosphorylated and is expressed in a wide variety of human tissues. It has higher identity to E2F4 than to other family members. Both this protein and E2F4 interact with tumor suppressor proteins p130 and p107, but not with pRB. Alternative splicing results in multiple variants encoding different isoforms. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.